scispace - formally typeset
A

Anders Larsson

Researcher at Uppsala University Hospital

Publications -  250
Citations -  72424

Anders Larsson is an academic researcher from Uppsala University Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 54, co-authored 198 publications receiving 55761 citations. Previous affiliations of Anders Larsson include Aarhus University & University of the Philippines.

Papers
More filters
Journal ArticleDOI

Cardiac troponin I in healthy Norwegian Forest Cat, Birman and domestic shorthair cats, and in cats with hypertrophic cardiomyopathy

TL;DR: The cTNI concentration increased with increasing severity of HCM, and Breed and sex may affect serum cTnI concentrations in healthy cats.
Journal ArticleDOI

Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function

TL;DR: Significant differences inSCr-concentrations between Minnesota/EKFC versus CRIC were observed in subjects with the same level of mGFR and equal demographic characteristics and can be explained by the difference in SCr-calibration.
Journal Article

Cathepsin S and cathepsin L in serum and synovial fluid in rheumatoid arthritis with and without autoantibodies

TL;DR: The differences in cathepsin S and cat hepsin L between RA patients with and without autoantibodies indicate that these cathepsypsins have a specific role in the disease process of seropositive RA, which may reflect the autoimmune activity and local inflammatory and matrix degrading process in the joint.
Journal ArticleDOI

Duodenum edema due to reduced lymphatic drainage leads to increased inflammation in a porcine endotoxemic model

TL;DR: In this article , the authors investigated if an impaired thoracic duct function can induce edema of the abdominal organs and if it is associated to increase inflammation when perfusion is maintained normal.
Journal ArticleDOI

Dynamic Changes in Pentraxin-3 and Neprilysin in ST Segment Elevation Myocardial Infarction

TL;DR: Survival analysis suggests that PTX3 might be a promising marker to predict mortality in this patient population of patients with ST segment elevation myocardial infarction.